{"id":"docosanol","rwe":[{"pmid":"41209321","year":"2025","title":"Homopolymerization and copolymerization of ε-caprolactone and l-lactide organocatalyzed by carboxylic acids with mono-, di-, and tri-functionality.","finding":"","journal":"RSC advances","studyType":"Clinical Study"},{"pmid":"40943411","year":"2025","title":"Topical and Systemic Therapeutic Approaches in the Treatment of Oral Herpes Simplex Virus Infection: A Systematic Review.","finding":"","journal":"International journal of molecular sciences","studyType":"Clinical Study"},{"pmid":"40757653","year":"2025","title":"Contact Freezing of Water Droplets by Crystalline Organic Acids.","finding":"","journal":"The journal of physical chemistry. A","studyType":"Clinical Study"},{"pmid":"40352543","year":"2025","title":"Nucleation and Supercooling Mitigation in Fatty Alcohol Phase Change Material Emulsions for Heat Transport and Storage.","finding":"","journal":"ACS omega","studyType":"Clinical Study"},{"pmid":"40141273","year":"2025","title":"Identification and Analysis of Cuticular Wax Biosynthesis Related Genes in Salicornia europaea Under NaCl Treatment.","finding":"","journal":"International journal of molecular sciences","studyType":"Clinical Study"}],"_fda":{"id":"b02d8fe2-0f76-44d9-ac83-037aaf714416","set_id":"07fc9c8d-dee7-4a69-bb7a-0f3001a4ebb3","openfda":{"upc":["0041260015571"],"unii":["9G1OE216XY"],"route":["TOPICAL"],"rxcui":["797534"],"spl_id":["b02d8fe2-0f76-44d9-ac83-037aaf714416"],"brand_name":["Cold Sore Fever Blister Treatment"],"spl_set_id":["07fc9c8d-dee7-4a69-bb7a-0f3001a4ebb3"],"package_ndc":["30142-869-07"],"product_ndc":["30142-869"],"generic_name":["DOCOSANOL"],"product_type":["HUMAN OTC DRUG"],"substance_name":["DOCOSANOL"],"manufacturer_name":["The Kroger Co."],"application_number":["ANDA212385"],"is_original_packager":[true]},"purpose":["Purpose Cold sore/fever blister treatment"],"version":"3","stop_use":["Stop use and ask a doctor if your cold sore gets worse or the cold sore is not healed within 10 days"],"warnings":["Warnings Allergy Alert: This product may cause a severe allergic reaction. Symptoms may include: hives facial swelling wheezing/difficulty shock rash If an allergic reaction occurs, stop use and seek medical help right away. For external use only"],"questions":["Questions or comments? Call 1-800-632-6900"],"do_not_use":["Do not use if you are allergic to any ingredient in this product"],"when_using":["When using this product apply only to the affected areas do not use in or near the eyes avoid applying directly inside your mouth do not share this product with anyone. This may spread the infection."],"effective_time":"20241017","active_ingredient":["Active ingredient Docosanol 10%"],"inactive_ingredient":["Inactive ingredients benzyl alcohol, light mineral oil, propylene glycol, purified water, sucrose distearate, sucrose stearate"],"indications_and_usage":["Uses treats cold sores/fever blisters on the face or lips shortens healing time and duration of symptoms: tingling, pain, burning, and/or itching"],"spl_unclassified_section":["Other information store at 20°-25°C (68°-77°F) do not freeze"],"dosage_and_administration":["Directions adults and children 12 years or over: wash hands before and after applying cream apply to affected area on the face or lips at the first sign of cold sore/fever blister (tingle). early treatment ensures the best results rub in gently but completely use 5 times a day until healed children under 12 years: ask a doctor"],"spl_product_data_elements":["Cold Sore Fever Blister Treatment Docosanol DOCOSANOL DOCOSANOL BENZYL ALCOHOL LIGHT MINERAL OIL PROPYLENE GLYCOL WATER SUCROSE DISTEARATE (HLB 5) SUCROSE STEARATE"],"keep_out_of_reach_of_children":["Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away."],"package_label_principal_display_panel":["Principal Display Panel COMPARE TO THE ACTIVE INGREDIENT IN ABREVA® COLD SORE TREATMENT PUMP† Docosanol Cream, 10% Cold Sore/Fever Blister Treatment Only FDA-approved medicine to shorten healing time* Portable convenient pump NET WT 2 g (0.07 oz) *Docosanol Cream, 10% contains the only OTC medicine approved by the FDA to shorten healing time and duration of symptoms. *Abreva® is a registered trademark of Haleon UK IP Limited RETAIN THIS INSERT FOR FULL PRODUCT USES, DIRECTIONS AND WARNINGS DISTRIBUTED BY THE KROGER CO. CINCINNATI, OHIO 45202","Package Label KROGER HEALTH Cold Sore Fever Blister Treatment Docosanol 10%"]},"tags":[{"label":"docosanol","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"D06BB11","category":"atc"},{"label":"Topical","category":"route"},{"label":"Cream","category":"form"},{"label":"Off-Patent","category":"patent"},{"label":"Generic Available","category":"availability"},{"label":"Mature","category":"status"},{"label":"Herpes labialis","category":"indication"},{"label":"Approved 2000s","category":"decade"},{"label":"Anti-Infective Agents","category":"pharmacology"},{"label":"Antiviral Agents","category":"pharmacology"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"DRUG INEFFECTIVE","source":"FDA FAERS","actionTaken":"7010 reports"},{"date":"","signal":"ORAL HERPES","source":"FDA FAERS","actionTaken":"2446 reports"},{"date":"","signal":"CONDITION AGGRAVATED","source":"FDA FAERS","actionTaken":"1953 reports"},{"date":"","signal":"DRUG ADMINISTRATION ERROR","source":"FDA FAERS","actionTaken":"1779 reports"},{"date":"","signal":"INCORRECT DRUG ADMINISTRATION DURATION","source":"FDA FAERS","actionTaken":"803 reports"},{"date":"","signal":"HERPES SIMPLEX","source":"FDA FAERS","actionTaken":"706 reports"},{"date":"","signal":"INCORRECT PRODUCT ADMINISTRATION DURATION","source":"FDA FAERS","actionTaken":"637 reports"},{"date":"","signal":"LIP SWELLING","source":"FDA FAERS","actionTaken":"552 reports"},{"date":"","signal":"WRONG TECHNIQUE IN PRODUCT USAGE PROCESS","source":"FDA FAERS","actionTaken":"550 reports"},{"date":"","signal":"PRODUCT QUALITY ISSUE","source":"FDA FAERS","actionTaken":"539 reports"}],"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[{"market":"United States","source":"CMS National Average Drug Acquisition Cost (NADAC)","asOfDate":"2024-01-03","unitCost":"$6.2345/GM","priceType":"NADAC","sourceUrl":"https://data.medicaid.gov/dataset/4j6z-xnwq","annualCost":"$2,276","description":"DOCOSANOL 10% CREAM","retrievedDate":"2026-04-07"}],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=DOCOSANOL","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:47:55.109303+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:47:55.692013+00:00"},"regulatory.us":{"url":"","method":"api_direct","source":"FDA Drugs@FDA","rawText":"","confidence":1,"sourceType":"fda_drugsfda","retrievedAt":"2026-04-20T00:47:54.236750+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=DOCOSANOL","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:47:56.005083+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:47:52.898230+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:47:52.898266+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T00:47:57.463451+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Envelope glycoprotein inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:47:57.061533+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200453/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:47:56.727726+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"ANDA212385","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:47:52.898270+00:00"}},"allNames":"abreva","offLabel":[],"synonyms":["docosanol","abreva","behenic alcohol","behenyl alcohol","docosyl alcohol","1-Docosanol"],"timeline":[{"date":"2000-07-25","type":"positive","source":"DrugCentral","milestone":"FDA approval"},{"date":"2024-03-01","type":"neutral","source":"FDA Orange Book","milestone":"Generic entry — 5 manufacturers approved"}],"approvals":[{"date":"2000-07-25","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Abreva","ecosystem":[{"indication":"Herpes labialis","otherDrugs":[{"name":"acyclovir","slug":"acyclovir","company":"Valeant Bermuda"},{"name":"penciclovir","slug":"penciclovir","company":"Denco Asset"},{"name":"valaciclovir","slug":"valaciclovir","company":"Glaxosmithkline"}],"globalPrevalence":null}],"mechanism":{"novelty":"Follow-on","modality":"Small Molecule","drugClass":"docosanol","explanation":"","oneSentence":"","technicalDetail":"Docosanol is a non-polymer, non-ionic surfactant that acts as a physical barrier to prevent the fusion of the herpes simplex virus with host cell membranes, thereby inhibiting viral entry and replication."},"commercial":{"launchDate":"2000","_launchSource":"DrugCentral (FDA 2000-07-25, )"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/940","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=DOCOSANOL","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=DOCOSANOL","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T10:44:34.820853","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:47:58.857995+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[{"drugName":"idoxuridine","drugSlug":"idoxuridine","fdaApproval":"1963-06-11","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"acyclovir","drugSlug":"acyclovir","fdaApproval":"1982-03-29","patentExpiry":"Mar 23, 2027","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"podophyllotoxin","drugSlug":"podophyllotoxin","fdaApproval":"1990-12-13","relationship":"same-class"},{"drugName":"inosine","drugSlug":"inosine","fdaApproval":"","relationship":"same-class"},{"drugName":"penciclovir","drugSlug":"penciclovir","fdaApproval":"1996-09-24","genericCount":4,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"imiquimod","drugSlug":"imiquimod","fdaApproval":"1997-02-27","patentExpiry":"Dec 11, 2029","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"sinecatechins","drugSlug":"sinecatechins","fdaApproval":"2006-10-31","patentExpiry":"Oct 2, 2026","patentStatus":"Patent protected","relationship":"same-class"}],"dataSources":[{"url":"https://data.medicaid.gov/dataset/4j6z-xnwq","name":"CMS National Average Drug Acquisition Cost (NADAC)","fields":["pricing"],"retrievedDate":"2026-04-07"}],"genericName":"docosanol","indications":{"approved":[{"name":"Herpes labialis","source":"DrugCentral","snomedId":1475003,"regulator":"FDA","eligibility":"No specific eligibility criteria mentioned for patient age, stage, or biomarkers. Suitable for patients with cold sores/fever blisters on the face or lips."}],"offLabel":[],"pipeline":[]},"currentOwner":"Haleon Us Holdings","drugCategory":"mature","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"idoxuridine","brandName":"idoxuridine","genericName":"idoxuridine","approvalYear":"1963","relationship":"same-class"},{"drugId":"acyclovir","brandName":"acyclovir","genericName":"acyclovir","approvalYear":"1982","relationship":"same-class"},{"drugId":"podophyllotoxin","brandName":"podophyllotoxin","genericName":"podophyllotoxin","approvalYear":"1990","relationship":"same-class"},{"drugId":"inosine","brandName":"inosine","genericName":"inosine","approvalYear":"","relationship":"same-class"},{"drugId":"penciclovir","brandName":"penciclovir","genericName":"penciclovir","approvalYear":"1996","relationship":"same-class"},{"drugId":"imiquimod","brandName":"imiquimod","genericName":"imiquimod","approvalYear":"1997","relationship":"same-class"},{"drugId":"sinecatechins","brandName":"sinecatechins","genericName":"sinecatechins","approvalYear":"2006","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT06558838","phase":"PHASE2","title":"Efficacy and Safety of Acyclovir-penciclovir Cream Versus an Abreva in the Suppression of Herpes Simplex Virus Eruptions","status":"COMPLETED","sponsor":"University of Utah","startDate":"2024-08-19","conditions":["Herpes Simplex Oral"],"enrollment":40,"completionDate":"2025-11-30"},{"nctId":"NCT04893577","phase":"PHASE2","title":"EDTA Eye Drops Compared to Abreva for Herpes Simplex Virus Eruptions","status":"COMPLETED","sponsor":"University of Utah","startDate":"2022-01-20","conditions":["Herpes Simplex Oral"],"enrollment":10,"completionDate":"2025-08-01"},{"nctId":"NCT06178367","phase":"PHASE3","title":"Effectiveness and Safety of Topical Hyaluronic Acid of Different Molecular Weights in Xerotic Skin Treatment","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2023-08-26","conditions":["Xerosis Cutis"],"enrollment":36,"completionDate":"2023-09-30"},{"nctId":"NCT06125912","phase":"NA","title":"A Comparative Split-Face Study of the Effects of a Retinol Alternative Cream on Improving Facial Skin Aging","status":"COMPLETED","sponsor":"Dime Beauty Co.","startDate":"2023-09-25","conditions":["Skin Aging"],"enrollment":35,"completionDate":"2024-02-15"},{"nctId":"NCT04872946","phase":"NA","title":"Topical and Oral Regimen for Skin Health","status":"COMPLETED","sponsor":"Integrative Skin Science and Research","startDate":"2019-11-26","conditions":["Skin Abnormalities"],"enrollment":74,"completionDate":"2020-05-07"},{"nctId":"NCT03977792","phase":"PHASE2","title":"An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis","status":"UNKNOWN","sponsor":"Laboratoire Boreaderme Inc.","startDate":"2020-09","conditions":["Recurrent Herpes Labialis"],"enrollment":164,"completionDate":"2022-07"},{"nctId":"NCT00467662","phase":"PHASE4","title":"Comparison of Topical Antiviral Agents for Labial Cold Sores (Herpes Labialis)","status":"UNKNOWN","sponsor":"Hadassah Medical Organization","startDate":"","conditions":["Reccurent Herpes Labialis"],"enrollment":75,"completionDate":""}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Topical","formulation":"Cream","formulations":[{"form":"CREAM","route":"TOPICAL","productName":"ABREVA"},{"form":"CREAM","route":"TOPICAL","productName":"Cold Sore Fever Blister"},{"form":"CREAM","route":"TOPICAL","productName":"Cold Sore Fever Blister Treatment"},{"form":"CREAM","route":"TOPICAL","productName":"Cold Sore Treatment"},{"form":"CREAM","route":"TOPICAL","productName":"DOCOSANOL"},{"form":"CREAM","route":"TOPICAL","productName":"Docosanol"},{"form":"CREAM","route":"TOPICAL","productName":"ABREVA"}]},"_patentsChecked":true,"crossReferences":{"NUI":"N0000179260","MMSL":"15675","NDDF":"009100","UNII":"9G1OE216XY","VUID":"4027425","CHEBI":"CHEBI:31000","VANDF":"4027425","RXNORM":"285039","UMLSCUI":"C0075770","chemblId":"CHEMBL1200453","ChEMBL_ID":"CHEMBL1200453","KEGG_DRUG":"D03884","DRUGBANK_ID":"DB00632","PUBCHEM_CID":"12620","SNOMEDCT_US":"411095000","MESH_SUPPLEMENTAL_RECORD_UI":"C529236"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"present","companyName":"Haleon Us Holdings","relationship":"Current Owner"}],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"0%"},"publicationCount":104,"therapeuticAreas":["Dermatology"],"atcClassification":{"source":"DrugCentral","atcCode":"D06BB11","allCodes":["D06BB11"]},"biosimilarFilings":[],"recentPublications":[{"date":"2025 Oct 31","pmid":"41209321","title":"Homopolymerization and copolymerization of ε-caprolactone and l-lactide organocatalyzed by carboxylic acids with mono-, di-, and tri-functionality.","journal":"RSC advances"},{"date":"2025 Sep 1","pmid":"40943411","title":"Topical and Systemic Therapeutic Approaches in the Treatment of Oral Herpes Simplex Virus Infection: A Systematic Review.","journal":"International journal of molecular sciences"},{"date":"2025 Aug 14","pmid":"40757653","title":"Contact Freezing of Water Droplets by Crystalline Organic Acids.","journal":"The journal of physical chemistry. A"},{"date":"2025 May 6","pmid":"40352543","title":"Nucleation and Supercooling Mitigation in Fatty Alcohol Phase Change Material Emulsions for Heat Transport and Storage.","journal":"ACS omega"},{"date":"2025 Mar 14","pmid":"40141273","title":"Identification and Analysis of Cuticular Wax Biosynthesis Related Genes in Salicornia europaea Under NaCl Treatment.","journal":"International journal of molecular sciences"}],"companionDiagnostics":[],"genericManufacturers":6,"_genericFilersChecked":true,"genericManufacturerList":["Alembic","Aurobindo Pharma Ltd","Dr Reddys","P And L","P And L Development","Sun Pharma Canada"],"status":"approved","companyName":"Haleon Us Holdings","companyId":"","modality":"Small molecule","firstApprovalDate":"2000","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2000-07-25T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":"2000-07-25T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":"2000-07-25T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"SA","regulator":"SFDA","status":"likely_approved","approval_date":"2000-07-25T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":"2000-07-25T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":"2000-07-25T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2018-11-19T00:00:00.000Z","mah":"P AND L","brand_name_local":null,"application_number":"ANDA208754"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2022-05-03T00:00:00.000Z","mah":"ALEMBIC","brand_name_local":null,"application_number":"ANDA215839"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2022-10-07T00:00:00.000Z","mah":"P AND L DEVELOPMENT","brand_name_local":null,"application_number":"ANDA212385"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2024-03-01T00:00:00.000Z","mah":"AUROBINDO PHARMA LTD","brand_name_local":null,"application_number":"ANDA217090"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2026-04-14T00:00:00.000Z","mah":"HALEON US HOLDINGS","brand_name_local":null,"application_number":"NDA020941"},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"pricingByCountry":[{"country_code":"Un","currency":"USD","price_amount":"2276.00","price_per":"year","price_type":"NADAC","annual_cost_usd":null,"reimbursement_status":null}],"trialStats":{"total":2,"withResults":1},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:47:58.857995+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}